Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children

NCT02640352 is registered in ClinicalTrials.gov with Probi AB as lead sponsor.

NCT NCT02640352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02640352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children
Lead sponsor
Probi AB
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
September 30, 2018
Enrollment
550 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper respiratory tract infections (common cold)